Company intelligence / Profile preview

AiPharma

Ownership: Private
Employees: ~50
Development stage: Phase 3

Overview

AiPharma Healthcare Sdn Bhd operates as a pharmaceutical distributor in Malaysia with a focus on sustainability for pharmacies and the broader pharmaceutical industry. The company partners with both chain and independent pharmacies nationwide and offers an expanding portfolio of pharmaceuticals, OTCs, medical devices, dermatological products, and consumer healthcare items. Products are available in over 1400 pharmacy outlets across Malaysia. No clinical development or proprietary drug pipeline reported.

Industry: Non-Academic Healthcare

Drug pipeline

1 asset

favipiravir

Phase 3

Indications: COVID-19

Partnerships

Robust partnerships with chain pharmacy and independent pharmacy networks across Malaysia

Beyond the preview

Go deeper on AiPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AiPharma.

Explore the full profile